JNJ | Johnson & Johnson

Johnson & Johnson To Spin Off Its Consumer Division and Focus On Pharmaceuticals
The announced shakeup is the biggest in the company's 135-year history.
By Precious Njoku | 1 week ago
JNJ

Endo will pay $63M to Texas as part of a settlement
Endo is to pay $63 million to Texas to settle claims made by the state and counties that the company was implicit in fueling the opioid crisis in the state.
By Precious Njoku | 2 weeks ago

Why Pfizer stock is making higher highs
Compared to its peers like Johnson and Johnson, and Merck, who are also vaccine manufacturers, Pfizer is a better bet and gives higher expected returns.
By Precious Njoku | 3 weeks ago

Are Biotech Stocks a Good Idea Right Now?
Take a look at a few trending biotech stocks and decide if this is something you want to invest in.
By Staff | 11 months ago

New York judge orders Johnson & Johnson to pay $120 million in damages to Brooklyn resident
Olson claimed that she got cancer because of asbestos exposure from Johnson & Johnson baby powder.
By Staff | 1 year ago
JNJ

Johnson & Johnson to acquire Momenta Pharmaceuticals for $6.5 billion
Johnson & Johnson to enroll 60,000 participants in the late-stage trial for its COVID-19 vaccine.
By Khan | 1 year ago
JNJ